Miller PD - Search Results

1

Bone and kidney disease: diagnostic and therapeutic implications.

Jamal SA, West SL, Miller PD. Jamal SA, et al. Among authors: miller pd. Curr Rheumatol Rep. 2012 Jun;14(3):217-23. doi: 10.1007/s11926-012-0243-9. Curr Rheumatol Rep. 2012. PMID: 22350608 Review.

2

Treatment of metabolic bone disease in patients with chronic renal disease: a perspective for rheumatologists.

Miller PD. Miller PD. Curr Rheumatol Rep. 2005 Mar;7(1):53-60. doi: 10.1007/s11926-005-0009-8. Curr Rheumatol Rep. 2005. PMID: 15760581 Review.

3

Treatment of osteoporosis in chronic kidney disease and end-stage renal disease.

Miller PD. Miller PD. Curr Osteoporos Rep. 2005 Mar;3(1):5-12. doi: 10.1007/s11914-005-0021-y. Curr Osteoporos Rep. 2005. PMID: 16036095 Review.

4

Effects of denosumab on fracture and bone mineral density by level of kidney function.

Jamal SA, Ljunggren O, Stehman-Breen C, Cummings SR, McClung MR, Goemaere S, Ebeling PR, Franek E, Yang YC, Egbuna OI, Boonen S, Miller PD. Jamal SA, et al. Among authors: miller pd. J Bone Miner Res. 2011 Aug;26(8):1829-35. doi: 10.1002/jbmr.403. J Bone Miner Res. 2011. PMID: 21491487 Free article. Clinical Trial.

5

Fracture risk assessment in patients with chronic kidney disease.

Jamal SA, West SL, Miller PD. Jamal SA, et al. Among authors: miller pd. Osteoporos Int. 2012 Apr;23(4):1191-8. doi: 10.1007/s00198-011-1781-0. Epub 2011 Sep 8. Osteoporos Int. 2012. PMID: 21901475 Review.

6

Secondary and tertiary hyperparathyroidism.

Jamal SA, Miller PD. Jamal SA, et al. Among authors: miller pd. J Clin Densitom. 2013 Jan-Mar;16(1):64-8. doi: 10.1016/j.jocd.2012.11.012. Epub 2012 Dec 23. J Clin Densitom. 2013. PMID: 23267748 Review.

7

Renal safety in patients treated with bisphosphonates for osteoporosis: a review.

Miller PD, Jamal SA, Evenepoel P, Eastell R, Boonen S. Miller PD, et al. J Bone Miner Res. 2013 Oct;28(10):2049-59. doi: 10.1002/jbmr.2058. J Bone Miner Res. 2013. PMID: 23907861 Free article. Review.

8

Teriparatide and bone turnover and formation in a hemodialysis patient with low-turnover bone disease: a case report.

Palcu P, Dion N, Ste-Marie LG, Goltzman D, Radziunas I, Miller PD, Jamal SA. Palcu P, et al. Among authors: miller pd. Am J Kidney Dis. 2015 Jun;65(6):933-6. doi: 10.1053/j.ajkd.2015.01.025. Epub 2015 Apr 2. Am J Kidney Dis. 2015. PMID: 25843705

9

Differential Effects of Teriparatide and Denosumab on Intact PTH and Bone Formation Indices: AVA Osteoporosis Study.

Dempster DW, Zhou H, Recker RR, Brown JP, Recknor CP, Lewiecki EM, Miller PD, Rao SD, Kendler DL, Lindsay R, Krege JH, Alam J, Taylor KA, Janos B, Ruff VA. Dempster DW, et al. Among authors: miller pd. J Clin Endocrinol Metab. 2016 Apr;101(4):1353-63. doi: 10.1210/jc.2015-4181. Epub 2016 Feb 9. J Clin Endocrinol Metab. 2016. PMID: 26859106 Free PMC article. Clinical Trial.

10

Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild-to-Moderate Chronic Kidney Disease.

Miller PD, Adachi JD, Albergaria BH, Cheung AM, Chines AA, Gielen E, Langdahl BL, Miyauchi A, Oates M, Reid IR, Santiago NR, Vanderkelen M, Wang Z, Yu Z. Miller PD, et al. J Bone Miner Res. 2022 Aug;37(8):1437-1445. doi: 10.1002/jbmr.4563. Epub 2022 May 20. J Bone Miner Res. 2022. PMID: 35466448 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

444 results

Search Page

Filters